Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma 1

Interventions

Cisplatin 127Carboplatin 126Drug Therapy 103Capecitabine 98Oxaliplatin 97Bevacizumab 97Radiotherapy 94Paclitaxel 86Gemcitabine 86tislelizumab 85Cyclophosphamide 84Specimen Handling 79pembrolizumab 77toripalimab 69Injections 65Magnetic Resonance Spectroscopy 64Fluorouracil 62sintilimab 57anlotinib 55130-nm albumin-bound paclitaxel 51Surgical Procedures, Operative 50Docetaxel 50fludarabine 46Pemetrexed 46Leucovorin 43venetoclax 42Standard of Care 42Biopsy 42Irinotecan 41lenvatinib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Thymopentin × Clear all
NCT06112041 2023-11-01

The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)

Second Affiliated Hospital of Soochow University

Phase 2 Not yet recruiting
29 enrolled
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡